Business Wire

TALKDESK

Share
Talkdesk Confirms Presence at All4Customer Event in Paris, Reinforces Commitment to French Market

Talkdesk®, Inc., a global AI-powered contact center leader for enterprises of all sizes, today announced its presence at the All4Customer event in Paris from March 26 - 28, 2024. Investment in the event is part of the company’s commitment to the French market and to driving exceptional outcomes for customers and partners across the region with the power of artificial intelligence (AI)-driven customer experience.

Simon Desvergez, enterprise solutions engineer at Talkdesk, will deliver a masterclass on supercharging contact center optimization with generative AI (GenAI) on Wednesday, March 27, 2024 at 12:00 p.m. in Masterclass 6. During the 45-minute session, industry professionals will hear examples of how GenAI has automated complex customer use cases and significantly improved the quality of self-service interactions.

The All4Customer event, which attracts approximately 15,000 attendees, is the latest example of continued commitment from Talkdesk to the French market. Over the past several months, Talkdesk has exhibited at the Customer Relationship and Marketing Meetings (CRM&M) event in Cannes to gain opportunities to meet face-to-face with local customer experience (CX) leaders and held the Talkdesk Partner Academy in Paris as an investment in its partner ecosystem.

Tiago Paiva, founder and chief executive officer at Talkdesk, commented: “France continues to be a significant business driver for the company, and we’re excited for 2024 to drive further local expansion for Talkdesk. All4Customer is an important opportunity for us to connect with local CX leaders in-person and discuss the value that deploying AI cloud technology can unlock in the contact center.”

Customers such as Quadient, a global leader in cloud-based business communication software, parcel locker solutions, and mailing systems technology based in Bagneux, France, uses Talkdesk to deliver frictionless customer interactions. Before implementing Talkdesk, 40% of Quadient’s call volume in some queues consisted of simple transactions that could be self-serviced to reserve agents’ time for more complex tasks. Quadient initially developed its self-service solutions with Talkdesk, then expanded to other Talkdesk tools, including a solution to assist with agent coaching and a voice bot. As a result, Quadient doubled its self-service capabilities, increased efficiency, and created better experiences for customers and agents.

Jackie James, director of global operations at Quadient, said: “The thing that I like about Talkdesk more than anything is that they're constantly looking for ways to improve. They’re regularly deploying features that have positive impacts on CX." As one example of this, James added: “By using a voice bot [to serve Parcel Pending], we could contain a lot of simple transactions just by walking the customer through a few steps and using some integrations with our web application. We immediately saw a 60% containment rate.”

FACYLE, a key partner of Talkdesk in the French market specializing in Consulting and CTI integration, expressed excitement about the ongoing collaboration. As a crucial launch partner, FACYLE has significantly contributed to the success of Talkdesk in France. FACYLE Chief Executive Officer Francois Breuiller highlighted the consistent investment from Talkdesk in the success of their partnership and the French market.

The Talkdesk-FACYLE partnership has led to notable achievements, including successful projects with Groupe APRIL and Groupe Monnoyeur. This success is attributed to dedication from Talkdesk in providing resources, materials, and events tailored for the French audience. These efforts have accelerated momentum, empowering enterprises to enhance customer experiences through the Talkdesk AI-powered contact center solutions.

Francois Breuiller further emphasized the positive impact of the partnership, stating: "Partnering with Talkdesk for the past two years has proven that we made the right choice for a pure CCaaS solution. We successfully implemented their solution on large customers’ projects, showcasing robustness and comprehensive feature coverage.”

The All4Customer event will take place at Paris Expo Porte de Versailles, Pavilion 4, where Talkdesk will exhibit in stand F28. For more information, visit www.all4customer-paris.com.

About Talkdesk

Talkdesk® is a global cloud contact center leader for enterprises of all sizes. Talkdesk CX Cloud and Industry Experience Clouds help enterprises deliver modern customer service their way. Our trusted, flexible, and innovative contact center platform leverages AI and automation to drive exceptional outcomes for their customers and improve the bottom line. Serving enterprise customers in over 100 countries, we partner with our customers to deliver continuous innovation and breakthrough results. Our unwavering commitment to doing what we say we will do and our investment in the highest levels of security and reliability for our products make us second to none in the industry. Improve customer experiences, increase efficiency, and grow revenue with Talkdesk, a cloud contact center platform built for your industry. Learn more and take a self-guided demo at www.talkdesk.com.

Talkdesk is a registered trademark of Talkdesk, Inc. All product and company names are trademarks™ or registered® trademarks of their respective holders. Use of them does not imply any affiliation with or endorsement by them.

To view this piece of content from cts.businesswire.com, please give your consent at the top of this page.

View source version on businesswire.com: https://www.businesswire.com/news/home/20240125676968/en/

About Business Wire

Business Wire
Business Wire
101 California Street, 20th Floor
CA 94111 San Francisco

http://businesswire.com
DK

Subscribe to releases from Business Wire

Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.

Latest releases from Business Wire

Sonrotoclax Data at ASH 2025 Confirm Foundational Potential Across B-cell Malignancies8.12.2025 00:00:00 CET | Press release

Novel BCL2 inhibitor sonrotoclax monotherapy demonstrates deep and durable clinical responses in R/R MCL and R/R CLLSonrotoclax in combination with BRUKINSA demonstrated rapid MRD negativity in treatment-naive CLL, regardless of high-risk features BeOne Medicines Ltd. (Nasdaq: ONC; HKEX: 06160; SSE: 688235), a global oncology company, today announced new data on sonrotoclax, a next-generation investigational BCL2 inhibitor, demonstrating meaningful clinical benefit as monotherapy and in combination across B-cell malignancies. These data were featured at the 67th American Society of Hematology (ASH) Annual Meeting & Exposition in Orlando, Florida. The five presentations highlight durable responses in heavily pretreated patients with relapsed/refractory (R/R) mantle cell lymphoma (MCL) and additional studies showing deep, rapid, and sustained undetectable minimal residual disease (uMRD) rates with sonrotoclax-based combinations in patients with treatment-naive chronic lymphocytic leukemi

Andersen Consulting tilføjer samarbejdsfirmaet Codezilla7.12.2025 21:19:00 CET | Pressemeddelelse

Andersen Consulting styrker sine kompetencer inden for digital transformation gennem en samarbejdsaftale med Codezilla, et firma med hovedsæde i Rumænien, der udvikler specialtilpasset software. Codezilla specialiserer sig i at udvikle skræddersyede softwareprodukter, der løser forretningsmæssige udfordringer gennem en tværfaglig tilgang, som kombinerer softwareudvikling med dybdegående marketingekspertise. Med over 30 år på markedet fungerer firmaet som implementerings- og digital konsulentressource for reklamebureauer, samtidig med at de arbejder med en bred kundebase, herunder virksomheder inden for sundhedssektoren og medicinsk udstyr. Codezillas interne teams strækker sig over teknik, design og strategi og leverer omnichannel-løsninger til både regionale og globale kunder. "Vi tror på, at fantastisk software er resultatet af solid ingeniørkunst og disciplineret eksekvering," udtaler Sebastian Doroftei, administrerende direktør for Codezilla. "Vores samarbejde med Andersen Consulti

Hemato-Oncology Trials: AOP Health Presents New Results at Top Congress ASH7.12.2025 17:00:00 CET | Press release

AOP Health continues to advance its clinical research program in myeloproliferative neoplasms, a special group of rare blood cancers. The company, specialized in rare diseases, presented the results of two scientific investigations at the 67th American Society of Hematology Association (ASH) Annual Meeting 2025 held in Orlando, FL, USA. The results provide new insights in treatment strategies. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20251207587915/en/ Dr. Martin Steinhart, CEO AOP Health; Photo credit: AOP Health/Studio Koekart ROP-ET and BESREMI PASS One of the clinical studies, ROP-ET, examined the use of ropeginterferon alfa-2b in people with essential thrombocythemia (ET), a disease in which the body produces too many platelets. The trial, a prospective, multicenter, single-arm phase III study, investigated the safety and efficacy of ropeginterferon alfa-2b in ET patients unable to receive available cytoreductive th

CoMotion GLOBAL 2025 Launches in Riyadh: Global Mobility Leaders Unite in Saudi Capital to Chart Urban Future7.12.2025 13:00:00 CET | Press release

Summit debuts Mayors in Motion initiative and CoMotion Urban Visionary Distinction as Riyadh showcases its rise as global mobility testbed Riyadh is rapidly becoming one of the world's most ambitious urban mobility laboratories, where next-generation technologies move from blueprint to real-world deployment on city streets at unprecedented scale. CoMotion GLOBAL 2025, the world's most influential gathering of urban mobility leaders, opens today in Riyadh for a three-day summit bringing together innovators from Africa, Asia, Europe, the Americas, and the Middle East. Running December 7-9, the event will explore how electrification, autonomy, AI-enabled transport, and giga-project urbanism are reshaping cities worldwide. The summit will spotlight everything from high-performance EVs and breakthrough autonomous fleets to emerging-market transport solutions and new mobility models, demonstrating how the Kingdom is opening new pathways for global mobility leadership. Strategic Partnerships

Deciphera Announces Oral Presentation of Positive Topline Results from Phase 2a Study of Sapablursen in Polycythemia Vera at the 67th American Society of Hematology (ASH) Annual Meeting6.12.2025 15:30:00 CET | Press release

Results from Phase 2a IMPRSSION study demonstrate sapablursen significantly reduced phlebotomy rate, controlled hematocrit and increased serum hepcidin Sapablursen was generally safe and well tolerated Results support further development of sapablursen in a Phase 3 study Deciphera Pharmaceuticals, a member of Ono Pharmaceutical Co., Ltd. (Headquarters: Osaka, Japan; President and COO: Toichi Takino; “Ono”), today announced the oral presentation of positive results from the Phase 2a IMPRSSION study of sapablursen in patients with polycythemia vera (PV) at the 67th American Society of Hematology (ASH) Annual Meeting, taking place December 6-9, 2025, in Orlando, FL. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20251206361611/en/ The results were presented by Ionis Pharmaceuticals, who discovered and developed sapablursen and conducted the IMPRSSION study. In March 2025, Ionis and Ono entered into a license agreement in which On

In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.

Visit our pressroom
World GlobeA line styled icon from Orion Icon Library.HiddenA line styled icon from Orion Icon Library.Eye